John G. Aunins, Chief Technology Officer & EVP at Seres Therapeutics, Inc. (MCRB), sold 18,780 shares at $23.89 ($449K) on 2016-03-28, disclosed to the SEC on 2016-03-29.
Open-market sale of $449k MCRB by Chief Technology Officer & EVP. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.89 | 9,390 | $224K | 50.0% |
| 2 | $23.89 | 9,390 | $224K | 50.0% |
| Total | $23.89 avg | 18,780 | $449K | 100% |
| Filing → |
| MCRB | SELL | 2018-10-16 | $170K | — | Filing → |
| MCRB | SELL | 2018-09-19 | $655K | — | Filing → |
| MCRB | SELL | 2018-07-18 | $231K | — | Filing → |